Skip to content
Disclosery

Exome Asset Management LLC

Follow

13F filer, CIK 2011932, NEW YORK, NY

Exome Asset Management LLC reported $134,501,159 across 63 holdings for the quarter ended 2025-06-30, in a 13F-HR/A filed 2025-08-15. Its ten largest share positions make up 40.01% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0001420506-25-002212

Period
2025-06-30
Reported value
$135M
Holdings
63
Top 10 weight
40.01%
New
29
Sold out
25

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ISHARES TRnew+200,000$7.35M
THCnew+27,000$4.75M
VSTMnew+599,900$2.49M
PRAXnew+59,002$2.48M
NEKTAR THERAPEUTICSnew+75,000$1.94M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AZNexited-32,534-$4.73M
AKROexited-76,379-$3.09M
VRDNexited-217,294-$2.93M
SVRAexited-836,397-$2.32M
ANABreduced-101,623-$2.26M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR/A 0001420506-25-002212, largest first. % of portfolio is the value over $121,280,311, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ISHARES TRISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 200,000 shares 200,000$7.35M6.06%new
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 211,000 shares; 2024Q4: 246,700 shares; 2025Q1: 165,496 shares; 2025Q2: 155,533 shares 155,533$6.72M5.54%-9,963Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 89,800 shares; 2024Q4: 147,800 shares; 2025Q1: 127,182 shares; 2025Q2: 98,182 shares 98,182$5.11M4.21%-29,000Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 905,126 shares; 2024Q4: 1,561,152 shares; 2025Q1: 3,215,457 shares; 2025Q2: 3,414,377 shares 3,414,377$4.81M3.97%+198,920Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 61,367 shares; 2025Q1: 135,616 shares; 2025Q2: 121,116 shares 121,116$4.79M3.95%-14,500Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 27,000 shares 27,000$4.75M3.92%newTimeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 621,678 shares; 2025Q2: 533,647 shares 533,647$3.83M3.16%-88,031Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 58,583 shares; 2024Q4: 65,883 shares; 2025Q1: 103,483 shares; 2025Q2: 115,817 shares 115,817$3.83M3.16%+12,334Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 54,738 shares; 2025Q1: 294,846 shares; 2025Q2: 397,846 shares 397,846$3.7M3.05%+103,000Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,447 shares; 2024Q4: 8,247 shares; 2025Q1: 4,673 shares; 2025Q2: 4,673 shares 4,673$3.64M3%0Timeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 77,285 shares; 2025Q1: 43,441 shares; 2025Q2: 41,641 shares 41,641$3.49M2.88%-1,800Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,427 shares; 2024Q4: 7,427 shares; 2025Q1: 6,358 shares; 2025Q2: 6,358 shares 6,358$3.46M2.85%0Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 64,516 shares; 2024Q4: 69,072 shares; 2025Q1: 61,656 shares; 2025Q2: 61,356 shares 61,356$3.25M2.68%-300Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 22,450 shares; 2024Q4: 22,450 shares; 2025Q1: 18,650 shares; 2025Q2: 18,650 shares 18,650$3.15M2.6%0Timeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 283,599 shares; 2025Q1: 689,137 shares; 2025Q2: 444,949 shares 444,949$3.06M2.52%-244,188Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 133,039 shares; 2024Q4: 77,439 shares; 2025Q1: 84,339 shares; 2025Q2: 84,339 shares 84,339$2.99M2.46%0Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 318,900 shares; 2025Q1: 337,198 shares; 2025Q2: 308,298 shares 308,298$2.89M2.38%-28,900Timeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 599,900 shares 599,900$2.49M2.05%newTimeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 59,002 shares 59,002$2.48M2.05%newTimeline
PENPENUMBRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 9,000 shares; 2025Q1: 9,000 shares; 2025Q2: 9,000 shares 9,000$2.31M1.9%0Timeline
89BIO INC89BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 300,600 shares; 2024Q4: 225,323 shares; 2025Q1: 353,882 shares; 2025Q2: 233,426 shares 233,426$2.29M1.89%-120,456
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 118,017 shares; 2025Q2: 153,278 shares 153,278$2.27M1.87%+35,261Timeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 138,152 shares; 2024Q4: 137,716 shares; 2025Q1: 142,744 shares; 2025Q2: 166,944 shares 166,944$2.19M1.81%+24,200Timeline
NEKTAR THERAPEUTICSNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 75,000 shares 75,000$1.94M1.6%new
WAYWAYSTAR HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 46,900 shares 46,900$1.92M1.58%newTimeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 289,690 shares; 2025Q2: 277,317 shares 277,317$1.91M1.58%-12,373Timeline
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 163,658 shares 163,658$1.9M1.56%newTimeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 258,391 shares; 2025Q2: 195,933 shares 195,933$1.87M1.54%-62,458Timeline
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 405,281 shares; 2025Q2: 226,060 shares 226,060$1.86M1.53%-179,221Timeline
UHSUNIVERSAL HLTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,100 shares 10,100$1.83M1.51%newTimeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 76,700 shares 76,700$1.81M1.49%newTimeline
CRNXCRINETICS PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 51,295 shares; 2025Q2: 62,700 shares 62,700$1.8M1.49%+11,405Timeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 100,367 shares; 2024Q4: 119,467 shares; 2025Q1: not reported; 2025Q2: 98,600 shares 98,600$1.71M1.41%newTimeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 59,900 shares; 2024Q4: 81,473 shares; 2025Q1: 71,438 shares; 2025Q2: 124,470 shares 124,470$1.63M1.35%+53,032Timeline
TRAVERE THERAPEUTICS INCTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 110,000 shares 110,000$1.63M1.34%new
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 196,500 shares; 2024Q4: not reported; 2025Q1: 60,600 shares; 2025Q2: 172,883 shares 172,883$1.55M1.28%+112,283Timeline
KARYOPHARM THERAPEUTICS INCKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,000,000 shares; 2024Q4: 2,000,000 shares; 2025Q1: 2,000,000 shares; 2025Q2: 2,000,000 shares 2,000,000$1.52M1.26%0
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 73,000 shares 73,000$1.49M1.22%newTimeline
SAREPTA THERAPEUTICS INCSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 2,000,000 shares 2,000,000$1.45M1.19%new
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 468,499 shares; 2024Q4: 1,097,999 shares; 2025Q1: 1,097,999 shares; 2025Q2: 1,097,999 shares 1,097,999$1.35M1.11%0Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 120,165 shares; 2024Q4: 151,965 shares; 2025Q1: 102,944 shares; 2025Q2: 53,744 shares 53,744$1.11M0.92%-49,200Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 47,000 shares; 2024Q4: 37,600 shares; 2025Q1: not reported; 2025Q2: 29,100 shares 29,100$1.03M0.85%newTimeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 133,113 shares; 2025Q2: 63,076 shares 63,076$720K0.59%-70,037Timeline
ALVOALVOTECHQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 90,100 shares; 2024Q4: 90,100 shares; 2025Q1: 90,100 shares; 2025Q2: 78,372 shares 78,372$715K0.59%-11,728Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 36,574 shares 36,574$662K0.55%newTimeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 213,544 shares 213,544$598K0.49%newTimeline
ESTAESTABLISHMENT LABS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 21,700 shares; 2024Q4: 13,100 shares; 2025Q1: 13,100 shares; 2025Q2: 13,100 shares 13,100$560K0.46%0Timeline
VYNEVYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 353,434 shares; 2024Q4: 353,434 shares; 2025Q1: 462,801 shares; 2025Q2: 208,970 shares 208,970$345K0.28%-253,831Timeline
TILINSTIL BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 16,200 shares 16,200$337K0.28%newTimeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 116,623 shares; 2025Q2: 15,000 shares 15,000$333K0.27%-101,623Timeline
ELDNELEDON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 256,373 shares; 2025Q1: 114,145 shares; 2025Q2: 114,145 shares 114,145$309K0.26%0Timeline
LQDALIQUIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 20,500 shares 20,500$255K0.21%newTimeline
ABUSARBUTUS BIOPHARMA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 28,300 shares; 2025Q1: not reported; 2025Q2: 75,484 shares 75,484$233K0.19%newTimeline
ELEVATION ONCOLOGY INC COMELEVATION ONCOLOGY INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 110,353 shares 110,353$40.5K0.03%new
MEREO BIOPHARMA GROUP PLCMEREO BIOPHARMA GROUP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 14,600 shares 14,600$39.6K0.03%new

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
AZNASTRAZENECA PLC-SPONS ADR ADRput28,362$3.93Mnew
AKROAKERO THERAPEUTICS INC COMput58,579$3.13Mnew
ACADACADIA PHARMACEUTICALS INC COMcall93,222$2.01Mnew
CORCENCORA INC Stockcall6,000$1.8Mnew
ULTRAGENYX PHARMACEUTICAL INULTRAGENYX PHARMACEUTICAL IN CALLcall37,500$1.36Mnew
UNHUNITEDHEALTH GROUP INC COMcall1,400$437Knew
ALTIMMUNE INCALTIMMUNE INC COM NEWput107,000$414Knew
FULCRUM THERAPEUTICS INCFULCRUM THERAPEUTICS INC COMcall20,000$138Knew

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AZNASTRAZENECA PLC-SPONS ADR32,534$4.73Mshares
AKROAKERO THERAPEUTICS INC76,379$3.09Mshares
VRDNVIRIDIAN THERAPEUTICS INC217,294$2.93Mshares
SVRASAVARA INC836,397$2.32Mshares
GEHCGE HEALTHCARE TECHNOLOGIES I25,400$2.05Mshares
IMNMIMMUNOME INC263,841$1.78Mshares
ONCBEONE MEDICINES LTD6,500$1.77Mshares
RDYDR REDDYS LABS LTD117,500$1.55Mshares
NEKTAR THERAPEUTICSNEKTAR THERAPEUTICS2,232,453$1.52Mshares
ARVNARVINAS INC195,295$1.37Mshares
TRVITREVI THERAPEUTICS INC163,738$1.03Mshares
BHVNBIOHAVEN LTD39,900$959Kshares
AKBAAKEBIA THREAPEUTICS INC189,087$363Kshares
TRAVERE THERAPEUTICS INCTRAVERE THERAPEUTICS INC110,000$231Kcall
ALDEYRA THERAPEUTICS INCALDEYRA THERAPEUTICS INC100,000$190Kput
NUVBNUVATION BIO INC96,311$170Kshares
CYTOKINETICS INCCYTOKINETICS INC23,000$141Kput
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INC37,500$129Kcall
RHYTHM PHARMACEUTICALS INCRHYTHM PHARMACEUTICALS INC40,000$70Kput
APREAPREA THERAPEUTICS INC28,972$59.1Kshares
GOSSAMER BIO INCGOSSAMER BIO INC100,000$47.5Kcall
NEKTAR THERAPEUTICS CMN STKNEKTAR THERAPEUTICS CMN STK75,000$22.5Kcall
ROIVANT SCIENCES LTDROIVANT SCIENCES LTD75,300$15.1Kput
VERU INCVERU INC60,000$900call
SOLENO THERAPEUTICS INCSOLENO THERAPEUTICS INC11,000$275put

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-25-002106 superseded2025-08-14acceptance time not in the bulk data set
13F-HR/A 0001420506-25-002212 baserestatement2025-08-15acceptance time not in the bulk data set